Skip to main content
RT @KDAO2011: Dr. P Crow #PhilipHenchLecture
IFN signature can parallel or predict flares #ACR21 @rheumnow https://t.co/

TheDaoIndex KDAO2011

4 years 10 months ago
Dr. P Crow #PhilipHenchLecture IFN signature can parallel or predict flares #ACR21 @rheumnow https://t.co/OskxDuKPDH
RT @AkhilSoodMD: Abstr 0579
Kim & Colleagues examined predictors of Tx change among RA patients w/ TNFi as 1st line

Akhil Sood MD AkhilSoodMD

4 years 10 months ago
Abstr 0579 Kim & Colleagues examined predictors of Tx change among RA patients w/ TNFi as 1st line biologic agent - Females & GC use more likely to switch agent - Vitamin D use & hx of other immune-mediated diseases (eg. Psoriasis, IBD) less likely to switch #ACR21 @RheumNow https://t.co/FM5mSWmSNA
RT @RichardPAConway: @zach_wallace_md on RTX vs CYC remission induction in AAV. Multivariable and propensity score match

Richard Conway RichardPAConway

4 years 10 months ago
@zach_wallace_md on RTX vs CYC remission induction in AAV. Multivariable and propensity score matching. No difference in ESRD or mortality. Real world confirmation of RAVE. Abstr#954 #ACR21 @RheumNow https://t.co/oSauqV8JnD
RT @DrPetryna: Abst0944 #ACR21 #ACRBest @RheumNow microbiom evaluation of MZ twins discordant for PSO reveals Ruminococ

Olga Petryna DrPetryna

4 years 10 months ago
Abst0944 #ACR21 #ACRBest @RheumNow microbiom evaluation of MZ twins discordant for PSO reveals Ruminococcus bromii species significantly reduced & two pathways related to tetrahydrofolate biosynthesis upregulated in PSO twins compared to their unaffected siblings (p< 0.05) https://t.co/67ao0l23sI
RT @ericdeinmd: #ACR21 Clinical Pearl: Beware of low cholesterol!
Systemic inflammation can lower cholesterol levels! Hi

Eric Dein ericdeinmd

4 years 10 months ago
#ACR21 Clinical Pearl: Beware of low cholesterol! Systemic inflammation can lower cholesterol levels! High inflammation and low cholesterol may INCREASE, not decrease risk of CVD! This is the "lipid paradox" @Rheumnow https://t.co/dK7hD8zkVP
RT @_Castillo_Pedro: Soluble urinary ALCAM previously shown as potential biomarker for LN. Further study showing urinary

Pedro Castillo _Castillo_Pedro

4 years 10 months ago
Soluble urinary ALCAM previously shown as potential biomarker for LN. Further study showing urinary ALCAM trended with changes in renal-SLEDAI and UPCr. #ACR21 Abst#3053 @RheumNow https://t.co/IqVJej7yda
RT @DrPetryna: Abst 0947 #ACR21 @RheumNow KikGR x TNFDARE/+ mice study assessed contribution of gut-derived T cells to i

Olga Petryna DrPetryna

4 years 10 months ago
Abst 0947 #ACR21 @RheumNow KikGR x TNFDARE/+ mice study assessed contribution of gut-derived T cells to increased joint inflammation through production of pro-inflammatory cytokines like IL-17 and TNF. Photolabeled gut-trafficked T cells are observed in the Achilles enthesis
RT @bella_mehta: Important to discuss men with #lupus
Nationwide claims study showed increased occurrence of multimorbi

Bella Mehta bella_mehta

4 years 10 months ago
Important to discuss men with #lupus Nationwide claims study showed increased occurrence of multimorbidity in men with SLE compared to women with SLE #ACR21 @RheumNow @AliDuarteMD Abst#0579 #ACRBest https://t.co/ljflGU84Ro
RT @uptoTate: No evidence to show increased risk of incident hypertension w/ TNFi use, after accounting for baseline &am

Dr. Rachel Tate uptoTate

4 years 10 months ago
No evidence to show increased risk of incident hypertension w/ TNFi use, after accounting for baseline & time-dependent confounding factors, in prospective AS cohort. Abs 0910 #ACR21 #RheumNow @RheumNow https://t.co/1SpQ51ftlK
RT @uptoTate: Ear dyspigmentation, scalp dyspigmentation and scarring alopecia found more frequently in Black DLE pts. F

Dr. Rachel Tate uptoTate

4 years 10 months ago
Ear dyspigmentation, scalp dyspigmentation and scarring alopecia found more frequently in Black DLE pts. Findings may help assist in dx and tx plans. Abs 0598 #ACR21 #RheumNow #ACRbest @RheumNow https://t.co/a1pxWHJ7b5
RT @drdavidliew: Does AAV induction choice (CYC v RTX) affect long-term outcomes (that might be missed in clinical trial

David Liew drdavidliew

4 years 10 months ago
Does AAV induction choice (CYC v RTX) affect long-term outcomes (that might be missed in clinical trials)? Boston data done two ways: multivar analysis & trial emulation using PS CYC and RTX-based induction both perform equally well over many years👍 #ACR21 ABST0954 @RheumNow https://t.co/8BZRgKiQNB
RT @RichardPAConway: Dr Strand presents HRQoL measures for avacopan from ADVOCATE trial. Better HRQoL outcomes with ava

Richard Conway RichardPAConway

4 years 10 months ago
Dr Strand presents HRQoL measures for avacopan from ADVOCATE trial. Better HRQoL outcomes with avacopan. Great to have PRO data. Abstr#0955 #ACR21 @RheumNow https://t.co/9qBAHETX7s
RT @uptoTate: French, real-world axSpA cohort analysis shows SEC and TNFi retention rates similar. What do you see in yo

Dr. Rachel Tate uptoTate

4 years 10 months ago
French, real-world axSpA cohort analysis shows SEC and TNFi retention rates similar. What do you see in your practice? Abs 0911 #ACR21 #RheumNow @RheumNow https://t.co/vu3zUwfktl https://t.co/v6DLjWJMn4
The RheumNow faculty have been glued to their monitors all day, watching video, and running down abstract presentations to find the best – several of these stood out as #ACRBests. Here is a listing of “Best” they saw on Day 1.
×